Compressible sodium caprate formulations
AssigneeAstraZeneca AB
InventorsHanna MATIC, Andreas RÅDEVIK
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a method of making an oral tablet comprising mixing a macromolecule with sodium caprate to form a mixture, and compressing the mixture into a tablet, wherein the sodium caprate is Form A. The present disclosure also provides a tablet made by the process provided herein. Also provided is a composition comprising sodium caprate and a macromolecule.
Claims45
A method of making an oral tablet, the method comprising
- a) mixing a macromolecule with sodium caprate to form a mixture;
- b) direct compressing the mixture to form a tablet;
- wherein the sodium caprate is Form A sodium caprate characterized by a wide-angle X-ray scattering (WAXS) spectrum which includes a peak at a region of 0.1 to 0.15 Å−1.
A method of making an oral tablet, the method comprising
- a) Wet granulating sodium caprate in a non-aqueous organic solvent to form granules;
- b) Drying and milling the granules
- c) Mixing the resulting granules with the macromolecules and other excipients
- d) Compressing the mixture to form a tablet;
- wherein the sodium caprate after step b) is Form A sodium caprate characterized by a wide-angle X-ray scattering (WAXS) spectrum which includes a peak at a region of 0.1 to 0.15 Å−1 and/or by an X-ray powder diffraction (XRPD) spectrum which includes a peak at 4° 2θ.
A method of making an oral tablet, the method comprising
- a) Wet granulating sodium caprate together with other excipients in a non-aqueous organic solvent to form granules;
- b) Drying and milling the granules
- c) Mixing the resulting granules with the macromolecules and optionally additional excipients;
- and
- d) Compressing the mixture to form a tablet;
- wherein the sodium caprate after step b) is Form A sodium caprate characterized by an X-ray powder diffraction (XRPD) spectrum which includes a peak at 4° 2θ.
A method of making an oral tablet, the method comprising
- a) Wet granulating sodium caprate together with a macromolecule and possibly other excipients in a non-aqueous organic solvent to form granules;
- b) Drying and milling the granules;
- c) Mixing the resulting granules with the other excipients;
- and
- d) Compressing the mixture to form a tablet;
- wherein the sodium caprate after step b) is Form A sodium caprate characterized by an X-ray powder diffraction (XRPD) spectrum which includes a peak at 4° 2θ.
A method of making an oral tablet, the method comprising
- a) sieving sodium caprate to obtain sodium caprate particles having a particle size of about 35 μm to about 1100 μm
- b) mixing the sodium caprate particles with a macromolecule to form a mixture;
- c) direct compressing the mixture of to form a tablet;
- wherein the sodium caprate is Form A sodium caprate characterized by a wide-angle X-ray scattering (WAXS) spectrum which includes a peak at a region of 0.1 to 0.15 Å−1 and/or by an X-ray powder diffraction (XRPD) spectrum which includes a peak at 4° 2θ and wherein the method does not comprise a wet granulation step, a drying step or a milling step after the mixing of step (a).
A composition comprising a macromolecule and sodium caprate, wherein the sodium caprate is Form A sodium caprate characterized by a wide-angle X-ray scattering (WAXS) spectrum which includes a peak at a region of 0.1 to 0.15 Å−1 and/or by an X-ray powder diffraction (XRPD) spectrum which includes a peak at 4° 2θ.
The composition of any one of claims 35 to 45, wherein the composition is in the form of an oral tablet, and the oral tablet has a tablet hardness tensile strength of above 0.5 MPa.
Dependencies are inferred from the claim text.